Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Hologic, Inc (NASDAQ: HOLX) closed at $67.13 in the last session, down -1.66% from day before closing price of $68.26. In other words, the price has decreased by -$1.66 from its previous closing price. On the day, 1.31 million shares were traded. HOLX stock price reached its highest trading level at $68.26 during the session, while it also had its lowest trading level at $67.09.
Ratios:
We take a closer look at HOLX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.02. For the most recent quarter (mrq), Quick Ratio is recorded 2.81 and its Current Ratio is at 3.55. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.
On August 06, 2025, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform but kept the price unchanged to $87. Citigroup Upgraded its Neutral to Buy on July 09, 2025, while the target price for the stock was maintained at $80.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 07 ’25 when Madaus Martin D bought 5,445 shares for $55.24 per share. The transaction valued at 300,760 led to the insider holds 5,445 shares of the business.
Mitchell Essex D sold 24,856 shares of HOLX for $1,897,482 on Dec 04 ’24. The Chief Operating Officer now owns 27,957 shares after completing the transaction at $76.34 per share. On Dec 04 ’24, another insider, Mitchell Essex D, who serves as the Officer of the company, bought 24,856 shares for $76.34 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOLX now has a Market Capitalization of 14930987008 and an Enterprise Value of 15821540352. As of this moment, Hologic,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.85, and their Forward P/E ratio for the next fiscal year is 14.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.70 while its Price-to-Book (P/B) ratio in mrq is 3.08. Its current Enterprise Value per Revenue stands at 3.917 whereas that against EBITDA is 12.67.
Stock Price History:
The Beta on a monthly basis for HOLX is 0.57, which has changed by -0.15782213 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, HOLX has reached a high of $84.39, while it has fallen to a 52-week low of $51.90. The 50-Day Moving Average of the stock is 1.76%, while the 200-Day Moving Average is calculated to be 1.28%.
Shares Statistics:
According to the various share statistics, HOLX traded on average about 2.57M shares per day over the past 3-months and 1870870 shares per day over the past 10 days. A total of 222.22M shares are outstanding, with a floating share count of 220.46M. Insiders hold about 0.88% of the company’s shares, while institutions hold 100.94% stake in the company. Shares short for HOLX as of 1753920000 were 4413873 with a Short Ratio of 1.72, compared to 1751241600 on 5584928. Therefore, it implies a Short% of Shares Outstanding of 4413873 and a Short% of Float of 2.6199998.
Earnings Estimates
Investors are keenly observing as 16.0 analysts analyze and rate the current performance of Hologic, Inc (HOLX) in the stock market.The consensus estimate for the next quarter is $1.09, with high estimates of $1.18 and low estimates of $1.02.
Analysts are recommending an EPS of between $4.25 and $4.19 for the fiscal current year, implying an average EPS of $4.24. EPS for the following year is $4.52, with 20.0 analysts recommending between $4.61 and $4.37.
Revenue Estimates
According to 15 analysts, the current quarter’s revenue is expected to be $1.03B. It ranges from a high estimate of $1.04B to a low estimate of $1.03B. As of the current estimate, Hologic, Inc’s year-ago sales were $987.9MFor the next quarter, 15 analysts are estimating revenue of $1.07B. There is a high estimate of $1.09B for the next quarter, whereas the lowest estimate is $1.05B.
A total of 19 analysts have provided revenue estimates for HOLX’s current fiscal year. The highest revenue estimate was $4.09B, while the lowest revenue estimate was $4.08B, resulting in an average revenue estimate of $4.09B. In the same quarter a year ago, actual revenue was $4.03BBased on 19 analysts’ estimates, the company’s revenue will be $4.27B in the next fiscal year. The high estimate is $4.31B and the low estimate is $4.22B.
